US EditionRovi Earns 97.7 Million Euros Until September, 14% Less, and Decreases Revenues by 7%
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Rovi obtained a net profit of 97.7 million euros in the first nine months of the year, a figure 14% lower than that of the same period of 2024, according to the pharmaceutical company reported this Thursday to the National Securities Market Commission (CNMV). Read
Rovi has obtained a net profit of 97.7 million euros in the first nine months of the year, a figure of 14% lower than that of the same period of 2024, according to the pharmaceutical company reported this Thursday to the National Securities Market Commission (CNMV).In particular, the gross operating result (Ebitda) of Rovi totaled 149.5 million euros until September, 11% less than in the same period last year, while the net operating result (Ebi…
Victor Galán analyzes markets: S&P 500 and Nasdaq retreat, while IBEX 35 and DAX Europe show strength
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
